Literature DB >> 1188356

Synthesis of (6-3H)-1alpha-hydroxyvitamin D3 and its metabolism in vivo to (3H)-1alpha,25-dihydroxyvitamin D3.

M F Holick, S A Holick, T Tavela, B Gallagher, H K Schnoes, H F DeLuca.   

Abstract

[6-3H]-1alpha-Hydroxyvitamin D3 was chemically synthesized and its full biological activity and radiochemical purity were demonstrated. With the use of this preparation it has been possible to demonstrate in vivo that in rats the [6-3H]-1Alpha-hydroxyvitamin D3 is converted to [6-3H]-1alpha,25-dihydroxyvitamin D3, the natural hormone. In fact, in the intestine and bone of rats given 32 picomoles of [6-3H]-1alpha-hydroxyvitamin D3 each day for 6 days, more than 80 percent of the lipid-soluble radioactivity exists as [6-3H]-1alpha,25-dihydroxyvitamin D3, a finding that suggests that much of the biological effectiveness of 1alpha-hydroxyvitamin D3 is due to its conversion to 1alpha,25-dihydroxyvitamin D3.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1188356     DOI: 10.1126/science.1188356

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  25-Hydroxyvitamin D3 regulation.

Authors:  M B Clark; J T Potts
Journal:  Calcif Tissue Res       Date:  1977-05

2.  Effects of 1 alpha-hydroxy vitamin D3 on the rachitic chick intestine: a comparison to the effects of 1,25-dihydroxyvitamin D3.

Authors:  D D Bikle; R N Empson; R L Morrissey; D T Zolock; T J Bucci; R H Herman; M M Pechet
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

3.  In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Haleem Z Shehabi; Edith K Y Tang; Heather A E Benson; Igor Semak; Zongtao Lin; Charles R Yates; Jin Wang; Wei Li; Robert C Tuckey
Journal:  Mol Cell Endocrinol       Date:  2013-12-29       Impact factor: 4.102

Review 4.  Novel activities of CYP11A1 and their potential physiological significance.

Authors:  Andrzej T Slominski; Wei Li; Tae-Kang Kim; Igor Semak; Jin Wang; Jordan K Zjawiony; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2014-11-13       Impact factor: 4.292

5.  Synthesis of 1 alpha-hydroxy[7-3H]cholecalciferol and its metabolism in the chick.

Authors:  S Edelstein; D Noff; D Freeman; M Sheves; Y Mazur
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

6.  Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet.

Authors:  J P Driver; O Foreman; C Mathieu; E van Etten; D V Serreze
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

7.  Protective effect of vitamin D3 analogues on endotoxin shock in mice.

Authors:  H Horiuchi; I Nagata; K Komoriya
Journal:  Agents Actions       Date:  1991-07

8.  Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.

Authors:  E Abe; C Miyaura; H Sakagami; M Takeda; K Konno; T Yamazaki; S Yoshiki; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea.

Authors:  M Makishima; J Okabe-Kado; Y Honma
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.